Time for reflection predicts the progression of renal dysfunction in patients with nondiabetic chronic kidney disease

Clinical and Experimental Hypertension

Volumn 31, Issue 3, 2009, Pages 220-230

  Takenaka, Tsuneo ^a   Mimura, Taku ^a   Kikuta, Tomohiro ^a   Kato, Nobutaka ^a   Inoue, Tsutomu ^a   Kanno, Yoshihiko ^a   Ohno, Yoichi ^a   Kobayashi, Tasuya ^a   Miyawaki, Yoshinori ^a   Suzuki, Hiromichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti hypertensive therapy; Augmentation index; Home blood pressure; Pulse wave velocity; Renal dysfunction

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSCLEROSIS; PREDICTOR VARIABLE; PROLIFERATIVE GLOMERULONEPHRITIS; PULSE WAVE; URINALYSIS; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CHRONIC DISEASE; ELASTICITY; KIDNEY; KIDNEY DISEASE; MANOMETRY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PULSATILE FLOW; RADIAL ARTERY; RETROSPECTIVE STUDY;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; CHRONIC DISEASE; CREATININE; DISEASE PROGRESSION; ELASTICITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MANOMETRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULSATILE FLOW; RADIAL ARTERY; RETROSPECTIVE STUDIES;

EID: 67649997685     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960902822476     Document Type: Article

References (22)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 2003; 108: 2154-2169.
2. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. Self-measured systolic blood pressure in the morning is a strong indicator of decline of renal function in hypertensive patients with non-diabetic chronic renal insufficiency. Clin Exp Hypertens 2002;24:249-260.
3. Takenaka T, Mimura T, Kanno Y, Suzuki H. Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol 2005;25:417-424.
4. Hashimoto J, Imai Y, O'Rourke MF. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens 2007;20:378-384.
5. London GM, Guerin AP, Pannier BM, Marchais SJ, Metivier F. Body height as a determinant of carotid pulse contour in humans. J Hypertens 1992;10:S93-95.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
7. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis 2007;50:927-937.
8. Takenaka T, Kobayashi K, Suzuki H. Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients. Atherosclerosis 2004;176:405-409.
9. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988;2:397.
10. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension 1996;27:130-135.
11. Mimura T, Takenaka T, Kanno Y, Moriwaki K, Okada H, Suzuki H. Vascular compliance is secured under angiotensin inhibition in non-diabetic chronic kidney diseases J Human Hypertens 2008;22:38-47.
12. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Horio S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-364.
13. McDonald DA. Regional pulse-wave velocity in the arterial tree. J Appl Physiol 1968;24:73-78.
14. Takenaka T, Suzuki H. New strategy to attenuate pulse wave velocity in haemodialysis patients. Nephrol Dial Transplant 2005;20:811-816.
15. Slatopolsky E, Hruska KA. Phosphorus, Calcium and Magnesium Metabolism in Diseases of the Kidney and Urinary Tract (7th ed.), Schrier RW, (ed.). Philadelphia, PA: Lippincott, Williams & Wilkins, 2001, pp. 2607-2660.
16. Amann K, Wolf B, Nichols C, Tornig J, Schwarz U, Zeier M, Mall G, Ritz E. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997;29:770-775.
17. Okada H, Watanabe Y, Kikuta T, Kobayashi T, Kanno Y, Sugaya T, Suzuki H. Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol 2004;15:2404-2413.
18. Middeke M, Klüglich M, Holzgreve H. Circadian blood pressure rhythm in primary and secondary hypertension. Chronobiol Int 1991;8:451-459.
19. Jerrard-Dunne P, Mahmud A, Feely J. Circadian blood pressure variation: Relationship between dipper status and measures of arterial stiffness. J Hypertens 2007;25:1233-1239.
20. Takenaka T, Minura T, Kanno Y, Ohno Y, Suzuki H. Arterial wave reflection is elevated in evening hemodialysis patients Clin Exp Hypertens 2008; 30: 173-181.
21. Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol 2002;17:543-551.
22. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006; 166: 846-852.